C. R. Bard, Inc. · Murray Hill, NJ United States ·(NYSE: BCR)
Company Description
- S&P 500
This link will open in a new window C. R. Bard is no upstart in the world of medical devices. The company has been in the business for more than a century and introduced the Foley urological catheter (still one of its top sellers) in 1934. Its products fall into four general therapeutic categories: vascular, urology, oncology, and surgical specialties. Among other things, the company makes stents, catheters, and guidewires used in angioplasties and other vascular procedures; urology catheters and products used to treat urinary incontinence; and catheters for delivering chemotherapy treatments. Its line of specialty surgical tools, made by subsidiary
Key C. R. Bard, Inc. Financials
| Company Type | Public - NYSE: BCR Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $2,452.1 |
| 2008 Employees | 11,000 |
C. R. Bard, Inc. Executives
| Title | Name & Bio | Contact |
| Chairman and CEO | Timothy Ring | Network |
| President, Asia, Americas | P. R. Curry | Network |
| President, Bard Canada | J. D. Kondrosky | Network |